Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Marlton › NPI 1235674912
Physician

Revive Spine and Pain Center

Revive Spine and Pain Center was paid $1.86M by Medicaid between Jan 2018 and Dec 2024, across 15 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.

33Billing provider infoREVIVE SPINE AND PAIN CENTER
MARLTON, NJ 08053
33aNPI1235674912assigned 01/04/2017
28Total paid$1.86M
24GClaims39,655
24DCodes billed15
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pain Medicine (Physical Medicine & Rehabilitation) Physician providers in New Jersey

Rank by total paid#1 of 15
Median peer was paid$15K
This provider vs. median126×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,886$175K
20192,251$126K
20204,961$250K
20215,378$280K
20228,405$411K
20239,377$377K
2024incomplete6,397$242K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 46% 15,377 13,596 $861K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 33% 9,204 6,527 $609K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 13% 10,611 8,291 $233K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2.9% 1,519 1,165 $54K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.9% 1,367 992 $53K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 160 160 $14K
20553 <1% 252 224 $10K
95911 <1% 63 63 $8K
95886 <1% 65 65 $6K
64493 <1% 36 36 $5K
64495 <1% 36 36 $3K
64494 <1% 36 36 $3K
3 more codes
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 720 $743.27
80305 <1% 116 $511.12
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 93 $351.82

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNAMMOUR, MIKE (MANAGER)